B Desablens

4.9k total citations
89 papers, 2.6k citations indexed

About

B Desablens is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, B Desablens has authored 89 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Pathology and Forensic Medicine, 30 papers in Genetics and 28 papers in Oncology. Recurrent topics in B Desablens's work include Lymphoma Diagnosis and Treatment (40 papers), Chronic Lymphocytic Leukemia Research (23 papers) and Acute Myeloid Leukemia Research (14 papers). B Desablens is often cited by papers focused on Lymphoma Diagnosis and Treatment (40 papers), Chronic Lymphocytic Leukemia Research (23 papers) and Acute Myeloid Leukemia Research (14 papers). B Desablens collaborates with scholars based in France, United States and Switzerland. B Desablens's co-authors include Bruno Cazin, J. Jaubert, Guillaume Dighiero, G. Tertian, Brigitte Dreyfus, Philippe Travade, M Leporrier, Karim Maloum, Jacques‐Louis Binet and Philippe Casassus and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

B Desablens

89 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B Desablens France 23 1.4k 1.2k 854 744 465 89 2.6k
Tak Takvorian United States 27 1.5k 1.1× 899 0.7× 957 1.1× 1.1k 1.5× 534 1.1× 58 2.9k
J L Harousseau France 22 1.8k 1.3× 815 0.7× 1.1k 1.3× 1.8k 2.4× 397 0.9× 36 3.3k
Françoise Rigal‐Huguet France 25 1.0k 0.7× 837 0.7× 1.3k 1.5× 869 1.2× 283 0.6× 66 2.7k
J R Redman United States 24 1.2k 0.8× 1.1k 0.8× 315 0.4× 662 0.9× 436 0.9× 34 2.1k
Aspasia Stamatoullas France 34 1.7k 1.2× 1.2k 1.0× 1.4k 1.6× 1.3k 1.8× 393 0.8× 126 3.6k
Marı́a Dolores Caballero Spain 32 1.4k 0.9× 586 0.5× 1.1k 1.3× 1.2k 1.6× 657 1.4× 74 2.8k
William S. Velasquez United States 29 2.5k 1.7× 1.3k 1.1× 459 0.5× 1.4k 1.8× 487 1.0× 58 3.5k
David Westerman Australia 27 1.4k 1.0× 1.4k 1.2× 732 0.9× 776 1.0× 545 1.2× 125 2.8k
Dominic Culligan United Kingdom 26 929 0.6× 504 0.4× 1.0k 1.2× 767 1.0× 586 1.3× 75 2.9k
Ester Orlandi Italy 26 771 0.5× 1.3k 1.0× 1.2k 1.4× 546 0.7× 218 0.5× 95 2.4k

Countries citing papers authored by B Desablens

Since Specialization
Citations

This map shows the geographic impact of B Desablens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Desablens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Desablens more than expected).

Fields of papers citing papers by B Desablens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Desablens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Desablens. The network helps show where B Desablens may publish in the future.

Co-authorship network of co-authors of B Desablens

This figure shows the co-authorship network connecting the top 25 collaborators of B Desablens. A scholar is included among the top collaborators of B Desablens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Desablens. B Desablens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Guillaume, Nicolas, Gilles Touati, Brigitte Pautard, et al.. (2005). ZAP-70 tyrosine kinase is constitutively expressed and phosphorylated in B-lineage acute lymphoblastic leukemia cells.. HAL (Le Centre pour la Communication Scientifique Directe). 3 indexed citations
4.
5.
Hunault, Mathilde, Nöel Milpied, Marc Bernard, et al.. (2001). Daunorubicin continuous infusion induces more toxicity than bolus infusion in acute lymphoblastic leukemia induction regimen: a randomized study. Leukemia. 15(6). 898–902. 17 indexed citations
6.
Pauwels, Marina, et al.. (2000). [Portal hypertension caused by intra-hepatic block during chronic lymphoid leukemia].. PubMed. 24(2). 221–4. 3 indexed citations
7.
Alliot, Carol, et al.. (2000). Neurosarcoidosis Associated with Hodgkin's Disease. Hematology. 5(4). 285–286. 4 indexed citations
8.
Harousseau, Jean‐Luc, Brigitte Witz, Bruno Lioure, et al.. (2000). Granulocyte Colony-Stimulating Factor After Intensive Consolidation Chemotherapy in Acute Myeloid Leukemia: Results of a Randomized Trial of the Groupe Ouest-Est Leucémies Aigues Myeloblastiques. Journal of Clinical Oncology. 18(4). 780–780. 56 indexed citations
9.
Camilleri‐Broët, Sophie, Antoine Martin, Philippe Moreau, et al.. (1998). Primary Central Nervous System Lymphomas in 72 Immunocompetent Patients: Pathologic Findings and Clinical Correlations. American Journal of Clinical Pathology. 110(5). 607–612. 114 indexed citations
10.
Decocq, Guillaume, B. De Cagny, Michel Andréjak, & B Desablens. (1997). [Acute kidney failure secondary to intravenous immunoglobulin administration. 4 cases and review of the literature].. PubMed. 51(5). 516–26. 9 indexed citations
11.
Quiquandon, I., et al.. (1995). Tuberculosis associated haemophagocytic syndrome: two cases with a favourable outcome.. PubMed. 37(2). 149–52. 7 indexed citations
12.
Labeille, B., et al.. (1993). [Acute febrile neutrophilic dermatitis (Sweet's syndrome) during therapeutic agranulocytosis in acute myeloblastic leukemia].. PubMed. 120(12). 884–8. 8 indexed citations
13.
Morel, Pierre, I. Quiquandon, Anne Janin, et al.. (1993). High incidence of lymphoid infiltration on labial salivary gland biopsy in non‐Hodgkin's lymphomas: clinical implications. British Journal of Haematology. 85(1). 93–98. 8 indexed citations
14.
Lévy, Raphaël, P Colonna, B Desablens, et al.. (1992). High-dose salvage chemotherapy without bone marrow transplantation for adult patients with refractory Hodgkin's disease.. Journal of Clinical Oncology. 10(7). 1086–1094. 39 indexed citations
15.
Desablens, B, et al.. (1992). La maladie de Hodgkin avec localisation médiastinale. Analyse de 78 patients traités par 3 cures d'ABVD-MP et radiothérapie. La Revue de Médecine Interne. 13(6). S34–S34. 1 indexed citations
16.
Gardembas-Pain, M, et al.. (1991). Home treatment of febrile neutropenia: An empirical oral antibiotic regimen. Annals of Oncology. 2(7). 485–487. 67 indexed citations
17.
Desablens, B, et al.. (1989). [Treatment of localized forms of Hodgkin's disease with 3 courses of chemotherapy (ABVD-MP) in combination with wide focal and prophylactic lumbo-splenic radiotherapy. The POF 81/12 protocol].. PubMed. 18(39). 1917–21. 7 indexed citations
18.
Andrieu, Jean‐Marie, et al.. (1988). HIV-Related Hematological Neoplasias in France. Recent results in cancer research. 112. 46–53. 10 indexed citations
19.
Desablens, B, et al.. (1984). Autoimmune Haemolytic Anaemia Associated with Bone Marrow Sarcoidosis. Acta Haematologica. 71(3). 204–206. 9 indexed citations
20.
Desablens, B, et al.. (1983). Chronic Lymphocytic Leukemia in Maghreb and Europe. Acta Haematologica. 69(4). 224–229. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tak Takvorian Breakdown of academic impact, for papers by J L Harousseau Breakdown of academic impact, for papers by Françoise Rigal‐Huguet Breakdown of academic impact, for papers by J R Redman Breakdown of academic impact, for papers by Aspasia Stamatoullas Breakdown of academic impact, for papers by Marı́a Dolores Caballero Breakdown of academic impact, for papers by William S. Velasquez Breakdown of academic impact, for papers by David Westerman Breakdown of academic impact, for papers by Dominic Culligan Breakdown of academic impact, for papers by Ester Orlandi
Rankless by CCL
2026